$3.59
-0.29-7.47%
Last update: Nov 6, 5:16 AM
Vanda Pharmaceuticals Inc
VNDANASDAQ
The average analyst price target for Vanda Pharmaceuticals is $13.07, 257.1% above the current price. Of 6 analysts, 5 rate it Buy and 1 Hold. Targets range from $7.50 to $20. The latest change came on Sep 23, 2026, when Oppenheimer initiated coverage of Vanda Pharmaceuticals with an Outperform rating and a $10 price target.
Price Target Range — 10 Quarters
Analyst Consensus — 6 Analysts
Rating Trend — Last 9 Months
